These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29265398)

  • 1. Process Improvement for Maximized Therapeutic Innovation Outcome.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2018 Jan; 103(1):8-12. PubMed ID: 29265398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2017 Jan; 101(1):8-12. PubMed ID: 27869291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to Application.
    Kilbourne AM; Braganza MZ; Bowersox NW; Goodrich DE; Miake-Lye I; Floyd N; Garrido MM; Frakt AB; Bever CT; Vega R; Ramoni R
    Med Care; 2019 Oct; 57 Suppl 10 Suppl 3(10 Suppl 3):S206-S212. PubMed ID: 31517789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking 'academic' drug discovery: the Manchester Institute perspective.
    Jordan AM; Waddell ID; Ogilvie DJ
    Drug Discov Today; 2015 May; 20(5):525-35. PubMed ID: 25542353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.
    Starokozhko V; Kallio M; Kumlin Howell Å; Mäkinen Salmi A; Andrew-Nielsen G; Goldammer M; Burggraf M; Löbker W; Böhmer A; Agricola E; de Vries CS; Pasmooij AMG; Mol PGM;
    Drug Discov Today; 2021 Feb; 26(2):283-288. PubMed ID: 33127567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure drug discovery: scarred or ready for remodeling?
    Plump A; Madwed J
    J Mol Cell Cardiol; 2011 Oct; 51(4):444-8. PubMed ID: 21854785
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology in cerebrovascular disease research: Pharmacokinetics-pharmacodynamics to the rescue.
    Feuerstein GZ
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):639-44. PubMed ID: 26661248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing the innovation supply chain to maximize personalized medicine.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2014 Feb; 95(2):113-8. PubMed ID: 24448453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs, health and the economy: investment, innovation, outcomes, growth.
    Montague T; Cavanaugh S; Skilton K; Szabo G; Sidel J; Gregoire JP
    Healthc Pap; 2002; 3(1):63-9; discussion 87-94. PubMed ID: 12811113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First, do no harm: single-use/single-dose vials.
    Neonatal Netw; 2013; 32(3):223-4. PubMed ID: 23807963
    [No Abstract]   [Full Text] [Related]  

  • 12. China's drug innovation and policy environment.
    Liang H; Ding J; Xue Y
    Drug Discov Today; 2011 Jan; 16(1-2):1-3. PubMed ID: 20546920
    [No Abstract]   [Full Text] [Related]  

  • 13. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How best practices are copied, transferred, or translated between health care facilities: A conceptual framework.
    Guzman G; Fitzgerald JA; Fulop L; Hayes K; Poropat A; Avery M; Campbell S; Fisher R; Gapp R; Herington C; McPhail R; Vecchio N
    Health Care Manage Rev; 2015; 40(3):193-202. PubMed ID: 24787750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connections in pharmacology: innovation serving translational medicine.
    Montero-Melendez T; Perretti M
    Drug Discov Today; 2014 Jul; 19(7):820-3. PubMed ID: 24316023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of new innovations: investing in evidence synthesis, generation and translation ensures public health innovations improve population health.
    Waters E
    Perspect Public Health; 2011 May; 131(3):103. PubMed ID: 21692389
    [No Abstract]   [Full Text] [Related]  

  • 17. Testing the Consolidated Framework for Implementation Research on health care innovations from South Yorkshire.
    Ilott I; Gerrish K; Booth A; Field B
    J Eval Clin Pract; 2013 Oct; 19(5):915-24. PubMed ID: 22762253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovation in therapeutics development at the NCATS.
    Colvis CM; Austin CP
    Neuropsychopharmacology; 2014 Jan; 39(1):230-2. PubMed ID: 24317308
    [No Abstract]   [Full Text] [Related]  

  • 19. The critical path initiative: leveraging collaborations to enhance regulatory science.
    Barratt RA; Bowens SL; McCune SK; Johannessen JN; Buckman SY
    Clin Pharmacol Ther; 2012 Mar; 91(3):380-3. PubMed ID: 22343813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical translation of cell-based pharmacogenomic discovery.
    Cox NJ; Gamazon ER; Wheeler HE; Dolan ME
    Clin Pharmacol Ther; 2012 Oct; 92(4):425-7. PubMed ID: 22910437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.